Posted by Michael Wonder on 23 Feb 2022
Medtronic receives FDA approval for InterStim X system, the next generation of the most personalised sacral nerve stimulation therapy for bladder and bowel control
22 December 2022 - New InterStim X system provides 10 to 15 years of battery life without the need to recharge.
Medtronic today announced it received approval from the U.S. FDA for InterStim X ― the next generation of the InterStim portfolio's recharge-free device – and it is available immediately.
